MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

11 Aug 2023 Evaluate
The Turnover for the quarter ended June 2023 of Rs. 29557.00 millions increase by 57.43% from Rs. 18775.00 millions.The Net Profit of the company vaulted to 135.57% to Rs. 7809.00  millions from Rs. 3315.00 millions in the previous quarter.Operating profit surged to 12234.00 millions from the corresponding previous quarter of 5960.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 29557.00 18775.00 57.43 29557.00 18775.00 57.43 87316.00 78369.00 11.42
Other Income 824.00 1551.00 -46.87 824.00 1551.00 -46.87 5484.00 1787.00 206.88
PBIDT 12234.00 5960.00 105.27 12234.00 5960.00 105.27 30028.00 20968.00 43.21
Interest 897.00 406.00 120.94 897.00 406.00 120.94 2782.00 1349.00 106.23
PBDT 11337.00 5554.00 104.12 11337.00 5554.00 104.12 25208.00 16426.00 53.46
Depreciation 1212.00 1231.00 -1.54 1212.00 1231.00 -1.54 4886.00 4787.00 2.07
PBT 10125.00 4323.00 134.21 10125.00 4323.00 134.21 20322.00 11639.00 74.60
TAX 2316.00 1008.00 129.76 2316.00 1008.00 129.76 5030.00 3060.00 64.38
Deferred Tax -48.00 -6.00 700.00 -48.00 -6.00 700.00 412.00 458.00 -10.04
PAT 7809.00 3315.00 135.57 7809.00 3315.00 135.57 15292.00 8579.00 78.25
Equity 1012.00 1024.00 -1.17 1012.00 1024.00 -1.17 1012.00 1024.00 -1.17
PBIDTM(%) 41.39 31.74 30.39 41.39 31.74 30.39 34.39 26.76 28.53
Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..